Tufts medical school dean joins drug maker's board

The dean of Tufts University’s medical school, Dr. Michael Rosenblatt (left), has joined British drug maker Shire PLC’s board of directors, the company said today.

Rosenblatt was previously director of the Harvard-MIT division of health sciences and technology and an executive with Merck Sharp & Dohme Research Laboratories, where he led drug-discovery efforts. (AP)